{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:04:41Z","timestamp":1780513481309,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.respe.2019.03.120","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T09:13:51Z","timestamp":1557306831000},"page":"261-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pr\u00e9valence des marqueurs de l\u2019h\u00e9patite B et statut vaccinal du personnel de sant\u00e9. Exp\u00e9rience de l\u2019h\u00f4pital militaire principal d\u2019instruction de Tunis"],"prefix":"10.1016","volume":"67","author":[{"given":"S.","family":"Zayet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Besghaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ben Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Belhadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bellaaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.respe.2019.03.120_bib0105","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/cid\/ciw605","article-title":"Hepatocellular Carcinoma and Viral Hepatitis in New York City","volume":"63","author":"Moore","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.respe.2019.03.120_bib0110","doi-asserted-by":"crossref","unstructured":"Hadj MB, Alaya NB, Bahri O. \u00c9valuation de la situation \u00e9pid\u00e9miologique de l\u2019infection par le virus de l\u2019h\u00e9patite B en Tunisie avant l\u2019introduction de la vaccination. \/data\/revues\/03987620\/v62sS4\/S0398762014003204\/ Internet]. 2014 Jul 27 [cited 2018 Mar 4]; Available from: http:\/\/www.emconsulte.com\/en\/article\/911583.","DOI":"10.1016\/j.respe.2014.05.098"},{"key":"10.1016\/j.respe.2019.03.120_bib0115","doi-asserted-by":"crossref","unstructured":"Pineau P, Tiollais P. La vaccination: atout majeur dans la lutte contre le cancer du foie induit par le virus de l\u2019h\u00e9patite B. \/data\/revues\/03698114\/v58i6\/S036981140900039X\/ [Internet]. 2010 Feb 12 [cited 2018 Mar 4]; Available from: http:\/\/www.emconsulte.com\/en\/article\/274505.","DOI":"10.1016\/j.patbio.2009.03.004"},{"issue":"537\u2013538","key":"10.1016\/j.respe.2019.03.120_bib0120","first-page":"19","article-title":"Vaccination contre l\u2019h\u00e9patite B\u00a0: politique vaccinale et populations cibles","volume":"27","author":"Bertholom","year":"2016","journal-title":"Option\/Bio"},{"issue":"1","key":"10.1016\/j.respe.2019.03.120_bib0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7150\/ijms.2.50","article-title":"Epidemiology and prevention of Hepatitis B virus infection","volume":"2","author":"Hou","year":"2005","journal-title":"Int J Med Sci"},{"issue":"2","key":"10.1016\/j.respe.2019.03.120_bib0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0749-3797(18)31357-6","article-title":"The prevalence of serological markers to Hepatitis A and Hepatitis B in drug abuse personnel","volume":"2","author":"Lange","year":"1986","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.respe.2019.03.120_bib0135","doi-asserted-by":"crossref","unstructured":"Besghaier H, Mrabet A, Doghri A, Belaj R, Ksontini R, Chebbi MK. Epid\u00e9miologie de l\u2019h\u00e9patite virale B en Tunisie. \/data\/revues\/03987620\/v60sS2\/S0398762012003793\/ [Internet]. 2012 Oct 8 [cited 2018 Mar 4]; Available from: http:\/\/www.emconsulte.com\/en\/article\/743628.","DOI":"10.1016\/j.respe.2012.06.271"},{"key":"10.1016\/j.respe.2019.03.120_bib0140","doi-asserted-by":"crossref","unstructured":"Hmida E, Craourc M, Chelli H, Gara M, Garbouj M, Boukraa N, et al. R\u00e9duction de moiti\u00e9 du taux de mortalit\u00e9 maternelle en Tunisie au cours des dix derni\u00e8res ann\u00e9es: apport de l\u2019\u00e9pid\u00e9miologie clinique \u00e0 la prise en d\u00e9cision en sant\u00e9 publique. \/data\/revues\/03987620\/v57sS1\/S039876200900145X\/ [Internet]. 2009 Apr 30 [cited 2018 Mar 4]; Available from: http:\/\/www.emconsulte.com\/en\/article\/211645.","DOI":"10.1016\/j.respe.2009.02.111"},{"key":"10.1016\/j.respe.2019.03.120_bib0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.aap.2012.01.011","article-title":"Age and years in practice as factors associated with needlestick and sharps injuries among health care workers in a Portuguese hospital","volume":"47","author":"Martins","year":"2012","journal-title":"Accid Anal Prev"},{"issue":"5","key":"10.1016\/j.respe.2019.03.120_bib0150","first-page":"e659","article-title":"Hepatitis B prevalence and risk factors in Morocco","volume":"60","author":"Sbai","year":"2012","journal-title":"Pathol Biol"},{"key":"10.1016\/j.respe.2019.03.120_bib0155","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1016\/S0399-077X(08)73255-4","article-title":"\u00c9pid\u00e9miologie de l\u2019h\u00e9patite virale B en Tunisie","volume":"38","author":"Bahri","year":"2008","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.respe.2019.03.120_bib0160","unstructured":"Belhadj A. Pr\u00e9valence des marqueurs viraux de l\u2019h\u00e9patite virale B: Etude prospective chez le personnel de l\u2019H\u00f4pital Militaire de Tunis (1787 cas). 2006."},{"issue":"27","key":"10.1016\/j.respe.2019.03.120_bib0165","first-page":"119","article-title":"Impact des recommandations sur la couverture vaccinale contre l\u2019h\u00e9patite B","author":"Guerin","year":"1997","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.respe.2019.03.120_bib0170","unstructured":"Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 1997; 46(RR-18):1-42."},{"key":"10.1016\/j.respe.2019.03.120_bib0175","doi-asserted-by":"crossref","unstructured":"Hachfi W, Abid M, Chaouech H, Fodha I, Trabelsi A, Jazia EB, et al. HEP-12 - Efficacit\u00e9 \u00e0 long du terme du vaccin contre le virus de l\u2019h\u00e9patite B en Tunisie. \/data\/revues\/0399077X\/v46i4sS1\/S0399077X16303894\/ [Internet]. 2016 Mar 8 [cited 2018 Mar 4]; Available from: http:\/\/www.emconsulte.com\/en\/article\/1072274.","DOI":"10.1016\/S0399-077X(16)30389-4"},{"issue":"1","key":"10.1016\/j.respe.2019.03.120_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medmal.2015.11.002","article-title":"Hepatitis B vaccination and adolescents: a lost generation","volume":"46","author":"Stahl","year":"2016","journal-title":"Med Mal Infect"},{"issue":"2","key":"10.1016\/j.respe.2019.03.120_bib0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jhin.2013.11.005","article-title":"Hepatitis B vaccination policies for student healthcare workers in Europe","volume":"86","author":"De Schryver","year":"2014","journal-title":"J Hosp Infect"},{"issue":"1","key":"10.1016\/j.respe.2019.03.120_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12026-015-8627-3","article-title":"Comment on: evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination","volume":"62","author":"Spira","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.respe.2019.03.120_bib0195","unstructured":"Costagliola D. Atteintes d\u00e9my\u00e9linisantes du syst\u00e8me nerveux central et vaccination contre l\u2019h\u00e9patite B: un nouvel \u00e9pisode de l\u2019interminable saga fran\u00e7aise! \/data\/revues\/03987620\/00560006\/08008560\/ [Internet]. 2008 Dec 12 [cited 2018 Mar 4]; Available from: http:\/\/www.emconsulte.com\/en\/article\/196111."},{"issue":"5","key":"10.1016\/j.respe.2019.03.120_bib0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0196-6553(97)90091-2","article-title":"Epidemiology of hepatitis B vaccine acceptance among urban paramedics and emergency medical technicians","volume":"25","author":"Lee","year":"1997","journal-title":"Am J Infect Control"}],"container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762019303311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762019303311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:41:27Z","timestamp":1759970487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0398762019303311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0398762019303311"],"URL":"https:\/\/doi.org\/10.1016\/j.respe.2019.03.120","relation":{},"ISSN":["0398-7620"],"issn-type":[{"value":"0398-7620","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pr\u00e9valence des marqueurs de l\u2019h\u00e9patite B et statut vaccinal du personnel de sant\u00e9. Exp\u00e9rience de l\u2019h\u00f4pital militaire principal d\u2019instruction de Tunis","name":"articletitle","label":"Article Title"},{"value":"Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.respe.2019.03.120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}